Compare · BDX vs MCK
BDX vs MCK
Side-by-side comparison of Becton Dickinson and Company (BDX) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. BDX focuses on Medical/Dental Instruments, while MCK focuses on Other Pharmaceuticals.
- MCK is the larger of the two at $122.63B, about 2.1x BDX ($57.93B).
- Over the past year, BDX is up 42.8% and MCK is up 25.2% - BDX leads by 17.6 points.
- BDX has been more active in the news (13 items in the past 4 weeks vs 11 for MCK).
- Both have 25 recent analyst ratings on file.
- Company
- Becton Dickinson and Company
- McKesson Corporation
- Price
- -
- -
- Market cap
- $57.93B
- $122.63B
- 1M return
- +9.48%
- +4.63%
- 1Y return
- +42.82%
- +25.19%
- Industry
- Medical/Dental Instruments
- Other Pharmaceuticals
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 13
- 11
- Recent ratings
- 25
- 25
Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest BDX
- BD Marks 85 Years of Essential Medical Device Manufacturing in Glen Falls, NY
- BD Named to TIME's 2027 List of America's Top Manufacturers
- Director Huffines Robert Luther was granted 158 units of Rights to Common Stock Under BD Deferred Compensation Plan (SEC Form 4)
- Director Byington Carrie L was granted 79 units of Rights to Common Stock Under 1996 Directors Deferral Plan (SEC Form 4)
- BD to Host Investor Day on December 10, 2026
- Chairman, CEO and President Polen Thomas E Jr exercised 20,239 shares at a strike of $178.94, returned $3,621,660 worth of shares to the company (17,246 units at $210.00) and sold $628,530 worth of shares (2,993 units at $210.00) as part of a pre-agreed trading plan (SEC Form 4)
- Becton Dickinson upgraded by Wells Fargo with a new price target
- Becton Dickinson and Company filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BD Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
- BD Board Increases Dividend for 55th Consecutive Year, Authorizes 10 Million Additional Share Repurchases
Latest MCK
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
- Gabelli Releases Agenda for 8th Annual Healthcare Symposium
- EVP, CIO and CTO Fraga Francisco sold $716,924 worth of shares (650 units at $1,102.96) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 4,414 units (SEC Form 4)
- EVP, CIO and CTO Fraga Francisco converted options into 398 shares, covered exercise/tax liability with 157 shares and sold $630,000 worth of shares (600 units at $1,050.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 5,064 units (SEC Form 4)
- SEC Form 144 filed by McKesson Corporation
- SEC Form S-8 filed by McKesson Corporation
- SEC Form 10-Q filed by McKesson Corporation
- McKesson Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
- McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 25-NSE filed by McKesson Corporation